Frederique Ph.D. Menzaghi Cara Therapeutics, Inc. (CARA) insider trading activity

Frederique Ph.D. Menzaghi is CHIEF SCIENTIFIC OFF,SVP-R&D of Cara Therapeutics, Inc.. Currently has a direct ownership of 167,247 shares of CARA, which is worth approximately $50,174. The most recent transaction as insider was on Feb 01, 2024, when has been sold 13,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 167K

0% 3M change

8.78% 12M change

Total Value Held $50,174

Frederique Ph.D. Menzaghi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2024	BUY Grant, award, or other acquisition	-	13,500 Added 7.47%	167,247 Common Stock
Jun 23 2023	SELL Open market or private sale	$10,505 $3.51 p/Share	2,993 Reduced 1.91%	153,747 Common Stock
Apr 04 2023	SELL Open market or private sale	$13,419 $4.91 p/Share	2,733 Reduced 1.71%	156,740 Common Stock
Mar 03 2023	SELL Open market or private sale	$66,047 $9.71 p/Share	6,802 Reduced 4.09%	159,473 Common Stock
Dec 21 2022	SELL Open market or private sale	$39,512 $11.27 p/Share	3,506 Reduced 2.07%	166,275 Common Stock
Apr 01 2022	SELL Open market or private sale	$21,247 $11.91 p/Share	1,784 Reduced 1.04%	169,781 Common Stock
Feb 25 2022	SELL Open market or private sale	$21,753 $10.29 p/Share	2,114 Reduced 1.22%	171,565 Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	20,000 Added 10.33%	173,679 Common Stock
Dec 17 2021	BUY Grant, award, or other acquisition	-	12,607 Added 7.58%	153,679 Common Stock
Aug 30 2021	SELL Open market or private sale	$54,627 $14.2 p/Share	3,847 Reduced 2.65%	141,072 Common Stock
Aug 24 2021	BUY Grant, award, or other acquisition	-	9,600 Added 6.21%	144,919 Common Stock
Mar 30 2021	BUY Grant, award, or other acquisition	-	16,000 Added 10.57%	135,319 Common Stock
Mar 05 2021	SELL Open market or private sale	$60,377 $17.98 p/Share	3,358 Reduced 2.74%	119,319 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	10,000 Added 7.54%	122,677 Common Stock
Feb 25 2021	SELL Open market or private sale	$96,708 $19.33 p/Share	5,003 Reduced 4.25%	112,677 Common Stock
Feb 23 2021	BUY Grant, award, or other acquisition	-	8,000 Added 6.37%	117,680 Common Stock
Dec 30 2020	SELL Open market or private sale	$43,024 $15.3 p/Share	2,812 Reduced 2.5%	109,680 Common Stock
Dec 23 2020	BUY Grant, award, or other acquisition	-	8,000 Added 6.64%	112,492 Common Stock

FPM

Frederique Ph.D. Menzaghi

CHIEF SCIENTIFIC OFF,SVP-R&D

Stamford, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CARA shares.

Notify only if

Value

Insider Trading

Get notified when an Cara Therapeutics, Inc. insider buys or sells CARA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cara Therapeutics, Inc.

Track Activities on CARA

Account